| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/20/1999 | WO1999024472A2 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 05/20/1999 | WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 05/20/1999 | WO1999024394A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 05/20/1999 | WO1999024391A1 Radio-opaque polymer biomaterials |
| 05/20/1999 | WO1999024080A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging |
| 05/20/1999 | WO1999024079A1 Improved labelled diagnostic compositions and methods of their use |
| 05/20/1999 | WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents |
| 05/20/1999 | WO1999024075A2 Affinity markers for human serum albumin |
| 05/20/1999 | WO1999024074A2 Novel conjugates of opioids and endogenous carriers |
| 05/20/1999 | WO1999017809A3 Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
| 05/20/1999 | WO1999015653A3 Tie ligand homologues |
| 05/20/1999 | CA2628053A1 Affinity markers for human serum albumin |
| 05/20/1999 | CA2309626A1 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 05/20/1999 | CA2309320A1 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 05/20/1999 | CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 05/19/1999 | EP0916963A1 Transverse relaxation-optimized NMR spectroscopy (TROSY) |
| 05/19/1999 | EP0916349A2 Method for monitoring cellular oxidative function |
| 05/19/1999 | EP0915902A1 Transgenic animals expressing artificial epitope-tagged proteins |
| 05/19/1999 | EP0915829A1 Diagnostic imaging contrast agent with improved in-serum-relaxivity |
| 05/19/1999 | EP0915738A1 Process and device for separating magnetic materials from pharmaceutical compositions, their starting or intermediate products and agents produced by means of this device |
| 05/19/1999 | CN1216925A Novel Dispersible lipid blends and uses therefor |
| 05/19/1999 | CN1216924A Diagnostic composition |
| 05/18/1999 | CA1340548C Method for producing native hiv gp160 |
| 05/14/1999 | WO1999023097A1 Substituted porphyrins |
| 05/14/1999 | WO1999022775A1 Methods for treating prostate tumors using radioactive compositions |
| 05/14/1999 | WO1999022774A1 Radioactive embolizing compositions |
| 05/14/1999 | WO1999002193A3 Triiodine aromates containing perfluoroalkyl groups, method for the production and use thereof as contrast agents |
| 05/14/1999 | CA2307191A1 Radioactive embolizing compositions |
| 05/14/1999 | CA2307190A1 Methods for treating prostate tumors using radioactive compositions |
| 05/12/1999 | EP0914431A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 05/12/1999 | EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 05/12/1999 | EP0914165A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 05/12/1999 | EP0914164A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds |
| 05/12/1999 | EP0914094A1 Materials and methods for making improved liposome compositions |
| 05/12/1999 | EP0525199B1 Composition containing ultrafine particles of magnetic metal oxide |
| 05/12/1999 | CN1216551A Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| 05/11/1999 | US5902839 Bone cement and method of preparation |
| 05/11/1999 | US5902310 Apparatus and method for marking tissue |
| 05/11/1999 | CA1340537C Polymer-bonded complexing agents, their complexes and conjugates, processes for their production and pharmaceutical agents containing them |
| 05/06/1999 | WO1999021978A1 Non-transgenic animal model of alzheimer's disease |
| 05/06/1999 | WO1999021592A1 Magnetic resonance imaging agents for the delivery of therapeutic agents |
| 05/06/1999 | WO1999010015A3 Method for producing contrast agents largely free of side-effects |
| 05/06/1999 | WO1998054301B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 05/06/1999 | EP0913161A2 Diagnostic agent for diabetes |
| 05/06/1999 | EP0913160A2 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria |
| 05/06/1999 | EP0912592A1 Phosphotriester oligonucleotides, amidites and method of preparation |
| 05/06/1999 | EP0912198A1 Immunoliposomes that optimize internalization into target cells |
| 05/06/1999 | EP0775104B1 Dimer dtpa derivatives and their metal complexes, pharmaceuticals containing the same, their use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals |
| 05/06/1999 | EP0742721B1 Methods of prolonged suppression of humoral immunity |
| 05/06/1999 | EP0688327B1 Analogs for specific oligosaccharide-protein interactions and uses therefor |
| 05/06/1999 | DE19726340C2 Zinndendrimere, ihre Verwendung als Röntgenkontrastmittel und Verfahren zu ihrer Herstellung Zinndendrimere, their use as X-ray contrast agents and methods for their preparation |
| 05/06/1999 | CA2307196A1 Non-transgenic animal model of alzheimer's disease |
| 05/05/1999 | CN1215986A Methods for preparing gas-filled liposomes |
| 05/04/1999 | US5900228 Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye |
| 05/04/1999 | US5900227 Multicyclic nitrone spin trapping compositions |
| 05/04/1999 | CA1340527C Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 04/29/1999 | WO1999020315A1 Methods of screening potential atypical antipsychotic drugs |
| 04/29/1999 | WO1999020312A1 Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug |
| 04/28/1999 | EP0911323A1 Biologically useful conjugates |
| 04/28/1999 | EP0911036A2 Dual carrier immunogenic construct |
| 04/28/1999 | EP0910415A1 Fluoro labelled anthracyclinone and anthracycline derivatives |
| 04/28/1999 | EP0910414A2 A diagnostic test for schizophrenia, using niacin |
| 04/28/1999 | EP0559738B1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 04/28/1999 | CN1215342A Contrast medium |
| 04/28/1999 | CN1215341A Bioactivated diagnostic imaging contrast agents |
| 04/28/1999 | CN1043143C Beta, beta-dihydroxy meso-substituted chlorin, bacteriochlorin, isobacteriochlorin and process for making same |
| 04/27/1999 | US5898586 Method for administering clinical trail material |
| 04/27/1999 | US5898094 Rodent models displaying enhanced alzheimer's disease phenotypic and physiological characteristics; produced by breeding modified rodents and comparing mutant offspring to nonmutant rodents |
| 04/27/1999 | US5897953 Granular polymer composite and production process thereof as well as diagnostic agent |
| 04/27/1999 | US5897851 Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging |
| 04/22/1999 | WO1999019473A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | WO1999019471A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | WO1999019466A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 04/22/1999 | WO1999019359A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | WO1999018998A2 Delivery system |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306443A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/21/1999 | EP0909817A1 Uses of gro genes and proteins |
| 04/21/1999 | EP0692981B1 Chelators of type xn 1?s 1?x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
| 04/21/1999 | EP0656368B1 Small-diameter composite composed of water-soluble carboxypolysaccharide and magnetic iron oxide |
| 04/21/1999 | EP0616538B1 Novel macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent |
| 04/21/1999 | EP0369000B1 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 04/21/1999 | CN1214264A Sulfanilamide derivative for diagnosis and treatment of tumor and its preparation |
| 04/20/1999 | US5895661 Liposome vesicle precursors |
| 04/15/1999 | WO1999017811A1 Enhancement of delivery of radioimaging and radioprotective agents |
| 04/15/1999 | WO1999017810A1 Methods of ultrasound imaging using echogenically persistent contrast agents |
| 04/15/1999 | WO1999017809A2 Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
| 04/15/1999 | WO1999017808A1 Ultrasound bubble recognition imaging |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1998059360A9 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2305627A1 Enhancement of delivery of radioimaging and radioprotective agents |
| 04/15/1999 | CA2304273A1 Ultrasound bubble recognition imaging |
| 04/14/1999 | EP0908187A1 Reagent for evaluating a hepatic operation |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907380A2 Pressure resistant protein microspheres as ultrasonic imaging agents |
| 04/14/1999 | EP0907379A2 Bioactivated diagnostic imaging contrast agents |
| 04/14/1999 | EP0595924B1 Platelet activating factor antagonists |